United Kingdom
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • CH
    • DK
    • PL
  • News
  • UK
  • World
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health
  • @
  • Artificial intelligence
  • Arts and design
  • Birmingham
  • Books
  • Boxing
  • Brexit
  • Bristol
  • Britain
  • Business
  • Celebrities
  • Computing
  • Cricket
  • Cycling
  • Economy
  • Edinburgh
  • England
  • Entertainment
  • Entrepreneurship
  • Environment
  • EU
  • F1
  • Fitness
  • Football
  • France
  • Gadgets
  • Genetics
  • Germany
  • Glasgow
  • Golf
  • Health
  • Healthcare
  • Internet
  • Jobs
  • Leeds
  • Liverpool
  • London
  • Manchester
  • Markets
  • Medication
  • Mental health
  • Mobile
  • Movies
  • Music
  • News
  • Northern Ireland
  • Nutrition
  • Personal finance
  • Physics
  • Racing
  • Royals
  • Rugby
  • Russia
  • Science
  • Scotland
  • Sheffield
  • Space
  • Spain
  • Sports
  • Technology
  • Tennis
  • TV
  • UK
  • Ukraine
  • United Kingdom
  • United States
  • Virtual reality
  • Wales
  • Wildlife
  • World
United Kingdom
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • CH
    • DK
    • PL
  • News
  • UK
  • World
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health
  • @

Browsing Tag

clinical development

7 posts
MMedication
Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Durvalumab Plus Chemotherapy in First-Line Advanced Biliary Tract Cancer in Single-Region Trial Conducted by Akeso in China
Read More

Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Durvalumab Plus Chemotherapy in First-Line Advanced Biliary Tract Cancer in Single-Region Trial Conducted by Akeso in China

  • 26 August 2026
HARMONi-GI1 Conducted in China by Akeso Is First Known Phase III Study in Advanced BTC to Demonstrate OS…
GGermany
Evinova Launches Strategic Partnership with Merck KGaA, Darmstadt, Germany to Define the Future of Clinical Development
Read More

Evinova Launches Strategic Partnership with Merck KGaA, Darmstadt, Germany to Define the Future of Clinical Development

  • 29 July 2026
Evinova’s full Study Designer with AI suite will be leveraged by Merck KGaA, Darmstadt, Germany to shape future…
UUnited States
IQVIA's Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States
Read More

IQVIA’s Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States

  • 16 July 2026
RESEARCH TRIANGLE PARK, N.C., July 16, 2026–(BUSINESS WIRE)–IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial…
BBristol
Bristol-Myers Squibb (BMY) Partners with Anthropic
Read More

Bristol-Myers Squibb (BMY) Partners with Anthropic

  • 29 May 2026
Bristol-Myers Squibb Company (NYSE:BMY) is one of the 12 Most Undervalued Stocks to Invest In. On May 20,…
BBristol
Hengrui Pharma and Bristol Myers Squibb Announce Strategic Agreements to Advance Innovative Medicines Across Oncology, Hematology, and Immunology
Read More

Hengrui Pharma and Bristol Myers Squibb Announce Strategic Agreements to Advance Innovative Medicines Across Oncology, Hematology, and Immunology

  • 12 May 2026
Landmark collaboration leverages complementary capabilities to drive speed in early innovation and help advance medicines for patients worldwide…
BBristol
Did UBS’s Pipeline-Driven Upgrade Just Shift Bristol-Myers Squibb’s (BMY) Investment Narrative?
Read More

Bristol-Myers Squibb Cancer Moves And Equity Efforts Underpin Valuation Case

  • 4 April 2026
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors…
GGenetics
SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines
Read More

SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines

  • 11 June 2025
Financing co-led by new investors EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as…
United Kingdom
www.europesays.com